Search research articles
Contact Us
Filters
Showing results (1-10 of 84) with videos related to
Page
of 9
Sort By:
Progress in Neurobiology
|
December 6, 2011
Ethical considerations of biomarker use in neurodegenerative diseases--a case study of Alzheimer's disease
David Prvulovic, Harald Hampel
Revista De Psiquiatria Y Salud Mental
|
March 1, 2013
[A paradigm shift in modern psychiatric diagnosis? Neural network dysfunction as a pathophysiological concept and novel diagnostic tool]
David Prvulovic, Harald Hampel
Current Opinion in Psychiatry
|
November 17, 2012
Novel biomarkers in major depression
Barbara Schneider, David Prvulovic
Clinical Chemistry and Laboratory Medicine
|
February 24, 2011
Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease
David Prvulovic, Harald Hampel
Expert Opinion on Drug Metabolism & Toxicology
|
May 3, 2014
Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease
David Prvulovic, Barbara Schneider
Expert Opinion on Drug Metabolism & Toxicology
|
February 2, 2010
Galantamine for Alzheimer's disease
David Prvulovic, Harald Hampel, Johannes Pantel
Psychiatry Research. Neuroimaging
|
October 7, 2018
Dental health in advanced age and Alzheimer's Disease: A possible link with bacterial toxins entering the brain?
Konrad Maurer, Sven Rahming, David Prvulovic
Current Treatment Options in Neurology
|
February 7, 2012
Treatment options for tauopathies
Tarik Karakaya, Fabian Fußer, David Prvulovic, et al.
Progress in Neurobiology
|
June 30, 2012
Blood and plasma-based proteomic biomarker research in Alzheimer's disease
Simone Lista, Frank Faltraco, David Prvulovic, et al.
Progress in Neurobiology
|
July 5, 2011
Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease
David Prvulovic, Arun L W Bokde, Frank Faltraco, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 84) with videos related to
Sort By:
Page
of 9
Progress in Neurobiology
|
December 6, 2011
Ethical considerations of biomarker use in neurodegenerative diseases--a case study of Alzheimer's disease
David Prvulovic, Harald Hampel
Revista De Psiquiatria Y Salud Mental
|
March 1, 2013
[A paradigm shift in modern psychiatric diagnosis? Neural network dysfunction as a pathophysiological concept and novel diagnostic tool]
David Prvulovic, Harald Hampel
Current Opinion in Psychiatry
|
November 17, 2012
Novel biomarkers in major depression
Barbara Schneider, David Prvulovic
Clinical Chemistry and Laboratory Medicine
|
February 24, 2011
Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease
David Prvulovic, Harald Hampel
Expert Opinion on Drug Metabolism & Toxicology
|
May 3, 2014
Pharmacokinetic and pharmacodynamic evaluation of donepezil for the treatment of Alzheimer's disease
David Prvulovic, Barbara Schneider
Expert Opinion on Drug Metabolism & Toxicology
|
February 2, 2010
Galantamine for Alzheimer's disease
David Prvulovic, Harald Hampel, Johannes Pantel
Psychiatry Research. Neuroimaging
|
October 7, 2018
Dental health in advanced age and Alzheimer's Disease: A possible link with bacterial toxins entering the brain?
Konrad Maurer, Sven Rahming, David Prvulovic
Current Treatment Options in Neurology
|
February 7, 2012
Treatment options for tauopathies
Tarik Karakaya, Fabian Fußer, David Prvulovic, et al.
Progress in Neurobiology
|
June 30, 2012
Blood and plasma-based proteomic biomarker research in Alzheimer's disease
Simone Lista, Frank Faltraco, David Prvulovic, et al.
Progress in Neurobiology
|
July 5, 2011
Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease
David Prvulovic, Arun L W Bokde, Frank Faltraco, et al.
Page
of 9